Showing results (61-70 of 90) with videos related to
Sort By:
Pageof 9
Biological Trace Element Research|August 6, 2011
Correlation between serum electrolytes and fasting glucose and Hb1Ac in Saudi diabetic patientsKhalid Al-Rubeaan, Khalid Siddiqui, Khaled Abu Risheh, et al.Plos One|March 4, 2014
Diabetic nephropathy and its risk factors in a society with a type 2 diabetes epidemic: a Saudi National Diabetes Registry-based studyKhalid Al-Rubeaan, Amira M Youssef, Shazia N Subhani, et al.Frontiers in Endocrinology|August 15, 2022
Proteomic profiling of thyroid tissue in patients with obesity and benign diffuse goiterHicham Benabdelkamel, Mohamed Rafiullah, Afshan Masood, et al.International Journal of General Medicine|May 5, 2022
Determinant of Osteopontin Levels in Microvascular Complications in Patients with DiabetesShaik Sarfaraz Nawaz, Khalid Siddiqui, Muhammad Mujammami, et al.Diabetes/Metabolism Research and Reviews|October 9, 2007
Genetic study of Saudi diabetes (GSSD): significant association of the KCNJ11 E23K polymorphism with type 2 diabetesOsama Alsmadi, Khalid Al-Rubeaan, Salma M Wakil, et al.Cardiovascular Diabetology|April 17, 2009
Changes in endotoxin levels in T2DM subjects on anti-diabetic therapiesOmar S Al-Attas, Nasser M Al-Daghri, Khalid Al-Rubeaan, et al.Current Medical Research and Opinion|November 7, 2022
Longitudinal assessment of the quality of life and patterns of antidiabetic medication use in patients with type 2 diabetes, Saudi Arabia perspective, DISCOVER studyKhalid Al-Rubeaan, Faisal Banah, Fayez G Alruwaily, et al.BMJ Open|August 30, 2023
Metabolic control and incidence of hypoglycaemia, hospitalisation and complications among Saudi patients with type 2 diabetes initiating second-line therapy: an analysis of the Saudi Arabia data from the DISCOVER Observational Study programmeKhalid Al Rubeaan, Faisal Banah, Fayez G Alruwaily, et al.Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|June 11, 2022
Characteristics and Treatment Patterns of Patients with Type 2 Diabetes Mellitus in the Middle East and Africa Cohort of the DISCOVER Study Program: a Prospective StudyKhalid Al-Rubeaan, Mohamed Alsayed, Abdullah Ben-Nakhi, et al.Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society|March 21, 2020
Physicians' choices in the first- and second-line management of type 2 diabetes in the Kingdom of Saudi ArabiaKhalid Al-Rubeaan, Faisal A Bana, Fayez G Alruwaily, et al.Pageof 9